AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Biohit Oyj

Share Issue/Capital Change Jun 8, 2018

3304_rns_2018-06-08_fb0e6cdb-d0b1-41e3-8927-67de21033b22.html

Share Issue/Capital Change

Open in Viewer

Opens in native device viewer

Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10

Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10

Biohit Oyj: Notice pursuant to the Finnish Securities Markets Act, Chapter 9, Section 10

Biohit Oyj

STOCK EXCHANGE RELEASE

June 8, 2018 at 3.40 PM

Biohit Oyj: Notice pursuant to the Finnish Securities Market Act, Chapter 9, Section 10

Biohit Oyj has received an announcement from Osmo Suovaniemi on June 8, 2018 in accordance with the Finnish Securities Market Act Chapter 9, Section 5.

According to the announcement, the total number of Biohit Oyj shares owned by Osmo Suovaniemi has decreased below fifteen (15) per cent of the share capital of Biohit Oyj on June 8, 2018.

Total positions of Osmo Suovaniemi according to the notification:

% of shares and voting rights % of shares and voting rights through financial instruments Total of both in % Total number of shares and voting rights of issuer
Resulting situation on the date on which the threshold was crossed or reached 13,56 % shares and 56,52 % votes 14 889 278 shares and

71 423 778 votes
Position of previous notification (if applicable) 34,76 % shares and 68,43 5 votes

Notified details of the resulting situation on the date on which the threshold was crossed or reached:

A: shares and voting rights:

Class / type of shares

ISIN-code
Number of shares and voting rights % of shares and voting rights
Direct

(SMA 9:5)
Indirect

(SMA 9:6 and 9:7)
Direct

(SMA 9:5)
Indirect

(SMA 9:6 ja 9:7)
FI0009005482 0 0 0 % 0 %
A-shares 2 018 310 shares and

40 366 200 votes
13,56 % shares and 56,52 % votes
SUBTOTAL A 2 018 310 shares and

40 366 200 votes
13,56 % shares and

56,52 % votes

B: Financial instruments according to SMA 9:6a

Type of Financial instrument Expiration date Exercise / Conversion period Physical or cash settlement Number of shares and voting rights % of shares and voting rights
SUBTOTAL B

Information on the party obliged to give notice of major shareholding:

Full chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held starting with the ultimate controlling natural person or legal entity:

Name % of shares and voting rights % of shares and voting rights through financial instruments Total of both
Osmo Suovaniemi 13,56 % shares and

56,52 % votes
2 018 310 shares and

40 366 200 votes
Interlab Oy 0 0

More information:

CEO Semi Korpela, Biohit Oyj

tel. +358 9 773 861

[email protected], www.biohit .fi

Biohit Oyj in brief

Biohit Oyj is a Finnish biotechnology company operating on a global scale. Biohit’s mission is “Innovating for Health” – we produce innovative products and services to promote research and early diagnosis. Biohit’s headquarters are located in Helsinki with subsidiaries in Italy and the UK.

Talk to a Data Expert

Have a question? We'll get back to you promptly.